Qiagen acquires DxS - MarketLine Financial Deals

Qiagen acquires DxS

Qiagen acquires DxS - MarketLine Financial Deals
Qiagen acquires DxS
Published Sep 22, 2009
3 pages — Published Sep 22, 2009
Price US$ 20.00  |  Buy this Report Now

About This Report


Qiagen N.V., a Netherlands-based provider of sample and assay technologies, has acquired all of the outstanding shares in DxS, Ltd., a UK-based personalized medicine company, for approximately $130 million.

Document ID
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author

Cite this Report

MarketLine Financial Deals. "Qiagen acquires DxS" Sep 22, 2009. Alacra Store. Oct 22, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Qiagen-acquires-DxS-2052-9093>
MarketLine Financial Deals. (2009). Qiagen acquires DxS Sep 22, 2009. New York, NY: Alacra Store. Retrieved Oct 22, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Qiagen-acquires-DxS-2052-9093>
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.